Lantheus to receive supply of LEU-derived Mo-99 from ANSTO

12/20/2009 | AuntMinnie.com (free registration)

The Australian Nuclear Science and Technology Organisation has agreed to provide U.S. firm Lantheus Medical Imaging with molybdenum-99 derived from low-enriched uranium for use in its TechneLite generator line being marketed in U.S. and Canada. Lantheus and ANSTO are working with U.S. and Canadian regulators to obtain the necessary approvals for the distribution of LEU-derived Mo-99 in U.S. and Canadian markets.

View Full Article in:

AuntMinnie.com (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Regional Director, Southeastern Region - State Affairs
America's Health Insurance Plans (AHIP)
Washington, DC
Field Representative-Oklahoma and Kansas
National Rural Electric Cooperative Association (NRECA)
Multiple Locations, SL_Multiple Locations
Market Intelligence Manager
Olympus Corporation of the Americas
Southborough, MA